Clinican BEAD-T1D: Building the Evidence to Address Disengagement in Type 1 Diabetes

NCT07491471 | Withdrawn DMC

• 2 other identifiers: 65313PK23DK131342
• Study Type: interventional
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

Youth with public insurance underutilize diabetes care, particularly diabetes technology which is associated with improvement in diabetes-specific outcomes. Thus, we urgently need studies to understand and increase diabetes technology utilization. This proposed research will (1) address the gap in knowledge of barriers and promoters in youth working with clinicians to identify and address factors associated with diabetes technology uptake and utilization.

Conditions

Type 1 Diabetes (T1D)

Keywords

Clinicians; Diabetes Technology

Outcome Measures

Primary Outcomes (3)

• Interviews with you on your feedback on the intervention

  The investigators will ask clincians questions in a 30-minute interview at the end of the four-week intervention. The investigators will evaluate feedback on ways the intervention could be more effective and what changes can be made to the intervention so that it is most effective. The investigators will ask clinicians if you they likely to change diabetes management after completing the intervention.

  Within 4 weeks upon intervention completion

• Survey questions on your feedback on the intervention

  The investigators will ask clincians questions in a feedback survey at the end of the four-week intervention. These questions will be developed by the investigators and will ask ways the intervention could be more effective and what changes can be made to the intervention so that it is most effective. Example questions of what the investigators plan to ask in the survey include: - Was the study explained appropriately? - Was it logistically easy to participate in the study? How could it have improved? - What parts of the intervention were most helpful? - What parts could be cut? - What parts need to be added? - Are there certain types of people who are likely to do better with this intervention?

  Within 4 weeks upon intervention completion

• Tracking people who complete the study

  The investigators will also keep track of who enrolled in the study and track how many people completed the intervention.

  Through study completion, an average of one year

Secondary Outcomes (1)

• Changes in diabetes technology usage

  Within 4 weeks upon intervention completion

Study Arms (1)

Pilot Intervention

EXPERIMENTAL

The design for this phase is a prospective pilot study. The intervention will be delivered weekly over a four-week period and will include pre- and post-intervention assessments of survey measurements. The investigators will evaluate rates of diabetes technology utilization. Virtual delivery of the pilot intervention will facilitate national recruitment.

Behavioral: Intervention to increase diabetes technology prescriptions

Interventions

Intervention to increase diabetes technology prescriptions BEHAVIORAL

The design for this phase is a prospective pilot study. The intervention modules will be delivered weekly over a four-week period and will include pre- and post-intervention assessments of survey measurements. We will recruit 20 clinicians to participate in the delivery of the pilot intervention.

Pilot Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• age 18+ years, providers who care for youth with T1D for at least 50% of their clinical efforts, practicing in the United States, care for youth with public insurance, health care role of physicians, advanced practice providers, or certified diabetes care \& education specialists, and understand and willingness to follow study protocol.

You may not qualify if:

• significant cognitive impairment or medical or psychiatric condition that would interfere with participation in the study or lack of access to a smartphone or Wi-Fi via computer.

Sponsors & Collaborators

• Stanford University: lead
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): collaborator

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes Mellitus; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases; Autoimmune Diseases; Immune System Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: May 20, 2025
• First Posted: March 24, 2026
• Study Start: August 15, 2025
• Primary Completion (Estimated): September 15, 2026
• Study Completion (Estimated): September 30, 2026
• Last Updated: March 24, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will not share